Celularity, Inc. (CELU)
1.23
-0.02
(-1.60%)
USD |
NASDAQ |
Feb 12, 16:00
1.21
-0.02
(-1.63%)
After-Hours: 20:00
Celularity Cash from Investing (Quarterly) : 0.00 for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Organogenesis Holdings, Inc. | -2.235M |
| ACADIA Pharmaceuticals, Inc. | -79.35M |
| Alnylam Pharmaceuticals, Inc. | 501.11M |
| Savara, Inc. | 21.47M |
| BioMarin Pharmaceutical, Inc. | -330.96M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.159M |
| Cash from Financing (Quarterly) | 3.478M |
| Free Cash Flow | -8.113M |
| Free Cash Flow Per Share (Quarterly) | -0.1579 |
| Free Cash Flow to Equity (Quarterly) | -0.767M |
| Free Cash Flow to Firm (Quarterly) | -2.682M |
| Free Cash Flow Yield | -27.41% |